Emcure Pharmaceuticals LtdPharmaceuticalsINE168P01015Consolidated₹2015.75+105.65 (+5.53%)Jun-26
Valuation
Market Cap₹38.01K Cr
TTM PE37.56x
Forward PE37.11x
PEG4.00
Book Value₹260.97
P/B7.68x
TTM EPS₹53.35
Fwd EPS₹54.00
TTM Revenue₹9.68K Cr
TTM PAT₹1.02K Cr
TTM EBITDA₹1.98K Cr
TTM EBIT₹1.56K Cr
Last Qtr PAT₹292.49 Cr
Last Qtr EBITDA₹532.51 Cr
Last Qtr EBIT₹423.00 Cr
Profitability
ROE20.59%
ROCE23.77%
TTM NPM10.52%
TTM EBITDA %20.45%
Curr OPM11.33%
Last OPM9.85%
Curr NPM—
Last NPM—
Curr EPS₹15.50
Last EPS₹12.84
Balance sheet
Equity₹189.59 Cr
Reserve₹4.76K Cr
Total Debt₹1,521.24 Cr
D/E0.31x
Interest %10.78%
Curr Interest₹31.54 Cr
Price / range
Close₹2003.80
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+4.92%
1W+1.97%
1M+7.31%
3M+15.04%
6M+31.55%
1Y+49.29%
2Y+31.26%
3Y—
5Y—
Diwali+42.79%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits